Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The NHS Innovation Accelerator (NIA) call for 2025 is now open in England

On September 1, 2024, the application window opened to join the NHS Innovation Accelerator (NIA) program in 2025. NIA is an NHS England Accelerated Access Collaborative initiative delivered in partnership with all 15 Health Innovation Networks (HINs), hosted at UCLPartners. NIA supports the development of individuals ('Fellows') and the spread of their innovation nationally.

The application can be submitted by individuals from any background, nationally and internationally, including industry (small and medium enterprise (SME), large corporate), clinicians, and academia.

The NIA specifically focuses on evidence-based innovations in their 'transition to scale' stage (when innovations that have demonstrated small-scale success develop their model and attract partners to help fill gaps in their capacity to scale).

For the 2025 intake, the NIA seeks high-impact, evidence-based innovations that can address any challenge the healthcare system faces. 

There are criteria that innovation should meet, including the following:

  • Address any of the current health and social care system priorities. There are no specific themes for the 2025 intake. The list of challenges indicated by stakeholders as being particularly pressing is provided for the information (includes digital and AI technologies in the areas of women's health, mental health, diabetes, pulmonary diseases, and remote clinical systems to improve healthcare delivery);
  • Address a clear need for patients or the health care system – in the prevention, diagnosis, treatment, or long-term management of a healthcare condition;
  • Address healthcare inequalities, especially in relation to population groups and major conditions in NHS England's Core20PLUS5 approach to reducing healthcare inequalities;
  • Are at the correct phase of maturity - applicants need to demonstrate that their innovation is already in use in a health or care system anywhere in the world, has been developed with the extensive involvement of users, is supported by a robust evidence base, and is ready to be used more widely across the NHS.

The application deadline is October 14, 2024.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags